Slovene Pharmaceutical Lek Takes Over Poland's Argon
Ljubljana, 8 October - The Slovene pharmaceutical company Lek has acquired a 89.45-percent stake in Poland's Argon in a takeover bid that concluded on 5 October. Argon's core business is the production of pharmaceutical agents, products and medicine, as well as medicine for self-treatment, Lek said on Monday.
The rest of this news item is available to subscribers.
The news item consists of 1.123 characters (without spaces) or 214 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.